Breaking News

Synerlab Acquires Lyofal

November 15, 2012

Gains lyophilization services

Synerlab, a French CMO, has acquired Lyofal, gaining access to the growing market of lyophilized dosage forms, and expanding its existing range of outsourcing services. Financial terms of the acquisition were not disclosed.
 
Lyofal’s core business is outsourcing lyophilization services, providing services from determining lyophilization parameters, formulation assistance, and improvement of existing cycles within R&D, to production of pilot and industrial scale for bulk products (APIs, plant or animal extracts), as well as vials (diagnostic use) or molded forms (haemostatic patches or medical devices).
 
blog comments powered by Disqus
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.